Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha interferon: a look to the future.

E M Bonnem

    Investigational New Drugs
    |January 1, 1987
    PubMed
    Summary

    Alpha-interferons show promise in treating various cancers, including AIDS-related Kaposi

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

    Leukemia & lymphoma·2016
    Same author

    Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.

    Circulation·1996
    Same author

    Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma.

    Investigational new drugs·1996
    Same author

    Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.

    Circulation·1995
    Same author

    Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.

    Annals of internal medicine·1992
    Same author

    alpha Interferon: the potential drug of adjuvant therapy: past achievements and future challenges.

    European journal of cancer (Oxford, England : 1990)·1991

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Alpha-interferons are a class of cytokines with known immunomodulatory and antiproliferative effects.
    • Their therapeutic potential in oncology has been investigated across diverse malignancies.

    Purpose of the Study:

    • To review the clinical applications and demonstrated activity of alpha-interferons in various cancer types.
    • To highlight promising areas of research for alpha-interferon therapy in oncology.

    Main Methods:

    • Literature review of studies investigating alpha-interferon treatment for cancer.
    • Analysis of reported clinical activity and outcomes in specific malignancies.

    Main Results:

    • Significant anti-cancer activity observed in AIDS-related Kaposi's sarcoma.
    • Demonstrated efficacy in ovarian carcinoma, bladder carcinoma, malignant glioma, non-Hodgkin's lymphoma, chronic granulocytic leukemia, carcinoid syndrome, and hairy cell leukemia.

    Conclusions:

    • Alpha-interferons exhibit significant therapeutic potential in a range of hematologic and solid tumors.
    • Further research is warranted to fully elucidate and optimize the use of alpha-interferons in cancer treatment.

    Related Experiment Videos